...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.
【24h】

Pharmacokinetics and inflammatory-fluid penetration of moxifloxacin following oral or intravenous administration.

机译:口服或静脉内给药后莫西沙星的药代动力学和炎性流体渗透。

获取原文
获取原文并翻译 | 示例
           

摘要

A single 400-mg oral or intravenous (i.v.) dose of moxifloxacin was given to each of eight healthy male volunteers, and 6 weeks later the dose was administered by the other route. The concentrations of the drug in plasma, cantharidin-induced inflammatory fluid, and urine were measured over the subsequent 24 h. The mean maximum concentrations observed in plasma were 4.98 microg/ml after oral dosing and 5.09 microg/ml after i.v. dosing. The mean maximum concentrations attained in the inflammatory fluid were 2.62 and 3.23 microg/ml, respectively. The mean elimination half-lives from plasma were 8.32 and 8.17 h, respectively. The overall penetration into the inflammatory fluid was 103.4 and 104.2%. Over 24 h 15% of the drug was recovered in the urine when administered by either route.
机译:向八位健康的男性志愿者分别口服400毫克的莫西沙星口服或静脉内(i.v.)剂量,并于6周后通过另一种途径给予该剂量。在随后的24小时内测量血浆,斑th素诱导的炎症液和尿液中药物的浓度。口服给药后血浆中观察到的平均最大浓度为4.98 microg / ml,静脉注射后为5.09 microg / ml。加药。在炎症液中获得的平均最大浓度分别为2.62和3.23 microg / ml。血浆的平均消除半衰期分别为8.32和8.17 h。整体渗透到炎症液中的比例为103.4和104.2%。通过任何一种途径给药后,在24小时内,尿液中都能回收到15%的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号